Pilot Study of a Fluocinolone Acetonide Intravitreal Insert (FA-i) to Treat Intermediate-, Posterior-, or Panuveitis

Trial Profile

Pilot Study of a Fluocinolone Acetonide Intravitreal Insert (FA-i) to Treat Intermediate-, Posterior-, or Panuveitis

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 02 May 2017

At a glance

  • Drugs Fluocinolone acetonide (Primary)
  • Indications Intermediate uveitis; Panuveitis; Posterior uveitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Apr 2017 Status changed from recruiting to active, no longer recruiting.
    • 06 Apr 2016 Study design changed from randomized to open label and number of arms changed from 2 to 1 as reported by ClinicalTrials.gov record.
    • 06 Apr 2016 Planned number of patients changed from 6 to 18 as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top